Daten des Robert Koch-Instituts: 7-Tage-Inzidenz & Hospitalisierungen & GrippeWeb-Wochenbericht
Das aktuelle Corona-Krankheitsaufkommen in Deutschland beträgt schätzungsweise 319 Fälle pro 100.000 Einwohner, was bedeutet, dass ca. eine von 219 Personen derzeit akut infiziert ist (angenommen sind Ø 10 Tage Infektionsdauer). Das Robert-Koch-Institut (RKI) meldet eine auf meldepflichtigen PCR-Tests basierte Inzidenz von 2, wobei auf jede offiziell registrierte Infektion etwa 154 weitere unentdeckte Fälle entfallen. Informationen zur aktuellen Verteilung zirkulierender SARS-CoV-2-Varianten finden sich im RKI-Dashboard.
Die auf dem GrippeWeb-Wochenbericht basierte Inzidenz aller Atemwegserkrankungen beträgt 11.153 pro 100.000 Einwohner, was bedeutet, dass ca. eine von 9 Personen derzeit akut infiziert ist (angenommen sind Ø 7 Tage Infektionsdauer; Vergleich zu den Vorjahren). Stand: 16.02.2026
Der Risikorechner macht infektiöse Aerosol-Gefahren in Innenräumen sichtbar und unterstützt dabei, das tatsächliche Ansteckungsrisiko realistisch einzuschätzen.
Risiko berechnen
Rund um das Immunsystem gibt es viele Mythen und Missverständnisse. Dieser Text klärt einige häufige Fragen wissenschaftlich fundiert auf.
Weiterlesen
The interplay between social connection and compliance with COVID-19 preventive measures. 16.02.2026
Safety and Tolerability of Multimodal Therapy (Ivermectin, Doxycycline, Vitamin C, Vitamin D, and Zinc) With or Without Famotidine in Australian Patients With COVID-19 Infection:A Pilot Cohort Trial. 16.02.2026
Intranasal SARS-CoV-2 infection changes the transcriptome of the mouse trigeminal ganglion and brainstem:potential mechanisms underlying headache and trigeminal pain presentation in COVID-19. 16.02.2026
EXPRESSION OF CONCERN:Culture and Identification of a “Deltamicron” SARS‐CoV‐2 in a Three Cases Cluster in Southern France 16.02.2026
Lymphopenia in Bacterial Sepsis and SARS-CoV-2 Infection 16.02.2026
SARS-CoV-2 Persistence and the Gut Microbiota:New Insights into Long COVID Pathogenesis 16.02.2026
In Search of the Most Significant Potential G-Quadruplexes in SARS-CoV-2 RNA:Genomic Analysis 16.02.2026
Development and characterization of mouse-adapted recombinant SARS-CoV-2 expressing reporter genes 16.02.2026
Detection of SARS-CoV-2 Neutralizing Antibodies and Vaccine Development 16.02.2026
Host MiRNA responses during different waves of SARS-CoV-2:diagnostic implications of miR-19a-3p, miR-374b-5p, miR-15b-5p, and miR-320a-5p expression 16.02.2026
Post-pandemic molecular and serologic detection of SARS-CoV-2 among vaccinated and unvaccinated participants in Yenagoa, Bayelsa State, Nigeria 16.02.2026
HLA-C–derived peptide MH-1 as an early-stage intervention against SARS-CoV-2 infection 16.02.2026
Hydrothermally Grown ZnO Nanowires on Silicon and Quartz:Multifunctional Coatings with Enhanced Antiviral Activity against SARS-CoV-2 16.02.2026
Association of SARS ‐ CoV ‐2 infection with interdonation interval:A matched cohort study of plasma donors in Québec, Canada 16.02.2026
The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances 16.02.2026
Lateral flow immunoassay of Fe3O4@PMAA@IgG nanoprobe for quick detection of SARS-CoV-2 based on natural color 16.02.2026
Intranasal SARS-CoV-2 infection changes the transcriptome of the mouse trigeminal ganglion and brainstem:potential mechanisms underlying headache and trigeminal pain presentation in COVID-19 16.02.2026
Computational Optimization of CRISPR-Cas13a sgRNAs Targeting the SARS-CoV-2 Spike Gene for SHERLOCK-Based Diagnostics 16.02.2026
Hydrothermally Grown ZnO Nanowires on Silicon and Quartz:Multifunctional Coatings with Enhanced Antiviral Activity against SARS-CoV-2. 15.02.2026
Severe traumatic brain injury:non-military patients' essential need for behavioural healthcare. 15.02.2026
Acquired Pure Red Cell Aplasia Following BNT162b2 mRNA COVID-19 Vaccination. 15.02.2026
Association of SARS-CoV-2 infection with interdonation interval:A matched cohort study of plasma donors in Québec, Canada. 15.02.2026
Comprehensive Engineering of Ionizable Lipid Nanoparticles and mRNA Elements for Next-Generation Vaccines. 15.02.2026
Antagonistic Ubiquitin Switching by USP7 and RNF40 Orchestrates KDM6A Homeostasis to License Coronavirus Susceptibility. 15.02.2026
Site-specific photosensitizer conjugation and anti-viral application of protein targeting SARS-CoV-2 15.02.2026
Clinical and Coronary Profile of SARS-CoV-2 Antibody–Positive Children with Incomplete Kawasaki Disease:A Retrospective Study 15.02.2026
Risk factors and Incidence Rate of Complications Originated as a Consequence of the Acute sars-cov-2 Infection or the Treatments Performed. A Longitudinal Study in General Medicine from march 15, 2020 to october 31, 2022 in toledo, Spain 15.02.2026
TNF inhibits SARS-CoV-2 induced cell-cell fusion through activating the SDC4-RhoA signaling to promote actin bundles formation 15.02.2026
HLA-E-restricted SARS-CoV-2 epitopes drive CD8(+) T cell memory in convalescent and vaccinated individuals:implications for the design of next-generation vaccines and immunotherapeutics. 14.02.2026
SARS-CoV-2 Infection disrupts lower respiratory tract microbiome function and interactions. 14.02.2026
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum. 14.02.2026
Longitudinal modeling of Post-COVID-19 condition over three years:A machine learning approach using clinical, neuropsychological, and fluid markers. 14.02.2026
Enabling global-scale nucleic acid repositories through versatile, scalable biochemical selection from room-temperature archives. 14.02.2026
The genomic diversity of SARS-CoV-2 Omicron lineages collected during routine sentinel surveillance in Tanzania between November 2022 and July 2023. 14.02.2026
Disturbed regulation of immunothrombosis in cerebral ischemia associated with SARS-CoV-2 infection 14.02.2026
Reatividade de anticorpos contra a proteína N de SARS-CoV-2 em pacientes com doença autoimune e em tratamento com anticorpo monoclonal 14.02.2026
Long‐Term Risk of Incident Type 2 Diabetes Following SARS‐CoV‐2 Infection:A Population‐Based Study in British Columbia, Canada 14.02.2026
Within-host invasion dynamics of SARS-CoV-2 through membrane fusion and endocytosis:a case study of a patient from a German hospital 14.02.2026
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum 14.02.2026
Analysis of Resistance to Antibiotics in a Strain of Opportunistic Bacteria in Tracheal Aspirate Cultures of SARS-COV-2 Patients Receiving Intensive Care 14.02.2026
HLA-E-restricted SARS-CoV-2 epitopes drive CD8+ T cell memory in convalescent and vaccinated individuals:implications for the design of next-generation vaccines and immunotherapeutics 14.02.2026
Correlation between the administration of SARS-CoV-2 vaccinations and infusion-related hypersensitivity reactions with taxane administration in patients with gynecologic malignancies 14.02.2026
Global Emergence and Spread of the XFG SARS-CoV-2 Variant and Its Clinical Profile Among XFG Patients in Maharashtra, India 14.02.2026
SARS-CoV-2 Antibody Responses during the Omicron Wave in Kano, Nigeria:Implications for Strengthening Future Vaccine Strategies 14.02.2026
A Paediatric Storm:SARS- CoV-2 Unleashing Acute Necrotising Encephalopathy, Hepatic Failure, and Kidney Injury in a Single Strike 14.02.2026
SARS-CoV-2 Infection disrupts lower respiratory tract microbiome function and interactions 14.02.2026
Genomic characterization of SARS-CoV-2 during the COVID-19 pandemic in Villa Clara, Cuba 14.02.2026
Computationally Efficient Network Models Successfully Predict Allosteric Sites of SARS ‐ CoV ‐2 Main Protease and Reveal Its Dynamic Allostery 14.02.2026
The genomic diversity of SARS-CoV-2 Omicron lineages collected during routine sentinel surveillance in Tanzania between November 2022 and July 2023 14.02.2026
Wastewater-based surveillance of respiratory viruses in a geriatric hospital:a pilot study. 13.02.2026
Detection of SARS-CoV-2 in aerosol and surface samples in high acuity hospital settings during community epidemic waves - implications for risk-based infection control. 13.02.2026
COVID-19 Impact on Lipid Profile and Metabolome in Patients with Type 2 Diabetes Mellitus:Mini-Review. 13.02.2026
Computationally Efficient Network Models Successfully Predict Allosteric Sites of SARS-CoV-2 Main Protease and Reveal Its Dynamic Allostery. 13.02.2026
Host proteins associated with strong neutralizing SARS-CoV-2 antibody responses in a South African cohort. 13.02.2026
Ultrasound effectively destabilizes and disrupts the structural integrity of enveloped respiratory viruses. 13.02.2026
Pathological characteristics of SARS-CoV-2 variants and immune responses induced in a COVID-19 macaque model. 13.02.2026
Evaluation of the efficiency of combined antiviral therapy in COVID-19 challenging immunocompromised patients. 13.02.2026
Immunometabolic function in patients with post-acute sequelae of SARS-CoV-2 infection:The PROMIS Study 13.02.2026
Oral and nasal mucosal neutrophils are defined by an interferon signature in patients infected with SARS-CoV-2 13.02.2026
Rapid discovery of repurposed drugs targeting SARS-CoV-2 spike HR1 by DNA-encoded library screening. 12.02.2026
Widespread ncaas Imprints in the Serum Proteome of COVID-19 Convalescents Uncovering Immune System Sequelae. 12.02.2026
Long-term Risk of Prediabetes and Type 2 Diabetes Following SARS-CoV-2 Infection:A Nationwide Cohort Study. 12.02.2026
Validation of "SARS-CoV-2 mRNA Vaccines Sensitize Tumors to Immune Checkpoint Blockade" in an Independent Cohort of 4,407 patients. 12.02.2026
Learning from patients about their experiences with early adoption of virtual care appointments in primary care in Ontario, Canada during the COVID-19 pandemic:a qualitative study. 12.02.2026
Safety and immunogenicity of a single dose of Ad26.COV2.S, BNT162b2, or SARS-CoV-2-rS-protein-nanoparticle in previously vaccinated and unvaccinated adults living with and without HIV in South Africa:a phase 2a randomised, observer-blind trial. 11.02.2026
Re:Vaccinating children against SARS-CoV-2 - parents' attitude. 09.02.2026
Letter to the editor:Use of the inactivated SARS-CoV-2 vaccine and the risk of Bell's palsy in China:A case-control study. 06.02.2026
Host Glycan-Lectin Interplay in SARS-CoV-2 Infection. 06.02.2026
Emergence of novel SARS-CoV-2 variants keeps slowing down 06.02.2026
Placental Vulnerability to SARS-CoV-2:Viral Entry Pathways, Immune Activation 06.02.2026
SARS-CoV-2 infection during pregnancy and neurodevelopmental outcomes in early childhood. 04.02.2026
Climatic factors drive global viral respiratory infections with regional heterogeneity:A systematic review and meta-analysis. 03.02.2026
SARS-CoV-2 Infection and Vaccination, Immune Dysregulation, and Cancer 03.02.2026
Rapid evolution reveals long-range spread of SARS-CoV-2. 03.02.2026
Non-SARS-CoV-2 respiratory tract infections in pediatric populations during the pandemic. 02.02.2026
Host Glycan–Lectin Interplay in SARS-CoV-2 Infection 01.02.2026
SARS-CoV-2 Chronic Intervillositis:Variations of Maternal Antiviral Response. 01.02.2026
Structural Basis and Inhibitor Development of SARS-CoV-2 Papain-like Protease 29.01.2026
Evaluation of the STANDARD M10 Flu/RSV/SARS-CoV-2 Fast assay for the detection of influenza A/B viruses, respiratory syncytial virus, and SARS-CoV-2 in nasopharyngeal swab specimens. 26.01.2026
Epigenetic Targeting of Obesity Genes by the SARS-CoV-2 Spike Protein 23.01.2026
Structural mimics of SARS-CoV-2. 22.01.2026
CACHE Challenge #3:Targeting the Nsp3 Macrodomain of SARS-CoV-2. 21.01.2026
Genetic Diversity of SARS-CoV-2 in Kazakhstan from 2020 to 2022. 21.01.2026
A feasibility study using the ETL CoronaCheck® device to identify incident cases of SARS-CoV-2:FIND SARS-CoV-2. 20.01.2026
Energy Measures as Biomarkers of SARS-CoV-2 Variants and Receptors. 16.01.2026
Genetic diversity and transmission dynamics of SARS-CoV-2 in East Africa. 14.01.2026
[Experiences from SARS-CoV-2 pandemic at UKSH Lübeck]. 13.01.2026
Dermato-neuro syndrome triggered by SARS-CoV-2 vaccination. 13.01.2026
Synergy of SARS-CoV-2 and HIV-1 Infections in the Human Brain. 13.01.2026
Host Responses to SARS-CoV-2 with an Emphasis on Cytokines. 09.01.2026
P-1608. Inactivating Effect of 222-nm Far Ultraviolet-C Irradiation on Aerosolized SARS-CoV-2 and SARS-CoV-2 in Solution 01.01.2026
P-1616. The Impact of SARS-COV-2 Pre-admission Screening on Hospital-Onset SARS-COV-2 Infections at an NYC Health System 01.01.2026
Non-Neutralising Antibodies and T Cell Responses to SARS-CoV-2 Detected in Unvaccinated SARS-CoV-2-Naive Spanish Adolescents. 01.01.2026
Selection and Characterization of SARS-CoV-2 Spike Binding Clickmers. 01.01.2026
Newly Diagnosed Crohn’s Disease After SARS‐CoV‐2 Infection 01.01.2026
Coinfection of SARS-CoV-2 and Influenza:A Catastrophic Coexistence. 23.12.2025
Radiology as a pillar in AI-based COVID-19 research:Insights from a diverse bibliometric analysis. 22.12.2025
Impact of prolonged infection on SARS-CoV-2 evolution. 05.12.2025
The Role of ACE2 in SARS-CoV-2 Infection, Pathogenesis, and Antiviral Interventions. 01.12.2025
Seroprevalence of SARS CoV 2 IgG in pandemic frontline healthcare workers 01.12.2025
Quellen: PubMed, Europe PMC & CrossRef
Long-Covid-Ambulanz kommt doch nicht - wien.ORF.at 16.02.2026
Covid Streit: Mehr als 170.000 Studierende klagen Unis - Tips.at 16.02.2026
COVID-19-Impfung: Tödlicher Trend - DocCheck 16.02.2026
Covid-19: mRNA-Impfstoff der nächsten Generation kommt - Pharmazeutische Zeitung 16.02.2026
Kritik an neuer Long-Covid-Ambulanz im Wiener AKH - Kurier 16.02.2026
Geplante Long-Covid-Ambulanz an AKH-Psychiatrie wird nicht bewilligt - derStandard.de | Nachrichten, Kommentare & Community 16.02.2026
Unerwünschte IgG4-Antikörper nach Covid-Booster - Infosperber 16.02.2026
Energiestoffwechsel des Gehirns bei Menschen mit Post-COVID gestört - Biermann Medizin 16.02.2026
Long Covid und ME/CFS: Der Kampf gegen rätselhafte Krankheiten - DNN - Dresdner Neueste Nachrichten 16.02.2026
Hunderte Betrugsfälle: Covid-Kredite bringen die Ostschweizer Behörden an den Anschlag - St. Galler Tagblatt 16.02.2026
Epidemiological changes in clavicle fractures during the COVID-19 pandemic: a six-year analysis from a large single-center cohort - springermedizin.de 14.02.2026
Biontech-Rivale Moderna wendet sich von US-Markt ab - Manager Magazin 13.02.2026
Covid-Impfung: Zweite Person erhält Entschädigung nach Corona-Impfung - Schweizer Fernsehen 13.02.2026
Endlich geklärt: Warum Long Covid Frauen dreimal so häufig trifft – die verblüffende Ursache - s-bahn.hamburg 13.02.2026
Grippe, Covid, Angina: Genesung dauert länger als gedacht - Apotheke Adhoc 13.02.2026
Long Covid setzte Florian Auer außer Gefecht. Als Dachspengler qualifizierte er sich für Olympia - derStandard.de | Nachrichten, Kommentare & Community 13.02.2026
Corona‑Varianten in Deutschland: Was man über Stratus und Nimbus wissen muss - Apotheken Umschau 13.02.2026
Gesundheitsausschuss diskutiert über Post-Covid-Versorgung - NDR.de 13.02.2026
COVID-19 - Auswärtiges Amt 07.02.2026
Entlarvung von Mythen und falschen Vorstellungen über Long COVID - World Health Organization (WHO) 30.01.2026
Quelle: Google News
Pluslife ist ein Molekulartest (PoC-NAT) für zuhause: besser als Antigen-Schnelltests bei niedriger Viruslast – und mit Analyzer-Webapp von »virus.sucks« werden Ergebnisse nachvollziehbar.
Safe Air Docs hilft dabei, Arztpraxen mit hohen Infektionsschutzstandards zu finden. So wird der Arztbesuch sicherer – besonders für Menschen mit erhöhtem Gesundheitsrisiko.
Am 15. und 16. Mai 2024 fand die virtuelle Konferenz #UniteToFight2024 statt und zog über 10.000 Teilnehmer an, die sich über die neuesten Entwicklungen zu Long Covid und ME/CFS informierten. Führende Experten wie Dr. David Putrino und Prof. Akiko Iwasaki präsentierten aktuelle Forschungsergebnisse.
Die Übertragung durch Aerosole ist einer der am schwierigsten zu vermeidenden Infektionswege, kann aber durch FFP2- und FFP3-Masken effektiv blockiert werden.
2023: Golda Schlaff und 15 weitere prominente Ärzt:innen fordern mehr Respekt vor den Patient:innen, die Wiedereinführung von FFP2-Masken bei steigenden Inzidenzen sowie den flächendeckenden Einsatz von HEPA-Filtern in medizinischen Einrichtungen.